EP Patent

EP4291196A1 — Methods for treating covid-19 with sepiapterin

Assigned to Virginia Commonwealth University · Expires 2023-12-20 · 2y expired

What this patent protects

The invention features methods of treating a SARS-CoV-2 infection in a subject, the method comprising administering to the subject an effective amount of sepiapterin or a pharmaceutically acceptable salt thereof.

USPTO Abstract

The invention features methods of treating a SARS-CoV-2 infection in a subject, the method comprising administering to the subject an effective amount of sepiapterin or a pharmaceutically acceptable salt thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP4291196A1
Jurisdiction
EP
Classification
—
Expires
2023-12-20
Drug substance claim
No
Drug product claim
No
Assignee
Virginia Commonwealth University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.